NCT06304077

Brief Summary

The aim of our study is to investigate the effects of landscapes during gait therapy. The investigators will evaluate the impacts of restorative landscapes as they occur in urban, rural and forest environments. Older people will experience those landscapes using virtual reality (VR) goggles during their gait training. The investigators expect the landscapes to have an effect on the following three aspects: (1) stress reduction, (2) restoration of attention and (3) change in gait parameters. For this purpose, volunteers who are currently inpatient in one of our study centers and already participating in gait therapy will be assigned to a group. The control group will receive the standard therapy. The participants of the intervention groups will receive five additional VR training sessions to the standard therapy. In these sessions, the participants will walk through urban, rural and forest landscapes and perform balance improvement exercises. The five training sessions will take place within ten days. Allocation to the control or intervention groups and their landscapes is random. At the start and end of participation, tests defining stress levels and gait parameters are carried out so that comparisons can be made between before and after treatment. The goal of the study is to find out which type of landscape supports restoration and can therefore contribute to greater gait stability. The investigators expect that improved gait stability will be promoted by stress reduction and increased attention induced by the virtual environments. The investigators are investigating the consequences of repeated application of virtual landscapes and the relationship between the effect of the landscape and the preferences and habits of the study participants.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 26, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

March 12, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

April 23, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2025

Completed
Last Updated

March 11, 2025

Status Verified

March 1, 2025

Enrollment Period

1.4 years

First QC Date

February 26, 2024

Last Update Submit

March 6, 2025

Conditions

Keywords

virtual reality (VR) based gait therapy

Outcome Measures

Primary Outcomes (1)

  • Gait Stability

    The German version of the Activities-specific Balance Confidence (ABC) Scale is used to assess balance self-confidence in older people. Self-report of fear of falling correlates with performance on the blindfolded and one-legged tests, and in addition, fear of falling can lead to activity limitation, resulting in a decline in physical performance. It has a 11-point response scale (no confidence 0% - 100% completely confident) and the overall score it calculated by summing the scores and dividing by the number of items (16). Cut-off scores are \< 50% (lower level of physical functioning), 50-80% (moderate level) and \> 80% (high level), a score smaller than 67% indicated a risk for falling. The ABC scale can be complected within 5-10 minutes.It could show an internal consistency of the ABC scale of 0.94 and a test-retest reliability of 0.85 (95% CI, 0.68, 0.93).

    at day 0 and day 11

Secondary Outcomes (17)

  • Variability (Gait Parameter)

    day 0 - 11

  • Speed (Gait Parameter)

    day 0 - 11

  • Asymmetry (Gait Parameter)

    day 0 - 11

  • Stance (Gait Parameter)

    day 0 - 11

  • Max. Heel Clearance (Gait Parameter)

    day 0 - 11

  • +12 more secondary outcomes

Other Outcomes (7)

  • Age (Demographic data)

    day 0

  • Height (Demographic data)

    day 0

  • Weight (Demographic data)

    day 0

  • +4 more other outcomes

Study Arms (4)

forest

EXPERIMENTAL

virtual reality (VR) assisted gait therapy in a forest landscape

Other: Forest

urban

EXPERIMENTAL

virtual reality (VR) assisted gait therapy in a urban landscape

Other: Urban

rural

EXPERIMENTAL

virtual reality (VR) assisted gait therapy in a rural landscape

Other: Rural

control

NO INTERVENTION

standard gait therapy

Interventions

ForestOTHER

Participants in the intervention groups will receive 5 VR training sessions over 10 days in addition to their usual care. Each participant will wear the HMD for 25 minutes in each of this training sessions, whereby he or she will first sit for 5 minutes looking at a forest-landscape. This is followed by 20 minutes of independent exploration of the virtual environment by walking. Depending on the user's gait stability, walking aids (such as walking sticks or rollators) may be used. This phase aims at keeping the participant walking.

forest
UrbanOTHER

Participants in the intervention groups will receive 5 VR training sessions over 10 days in addition to their usual care. Each participant will wear the HMD for 25 minutes in each of this training sessions, whereby he or she will first sit for 5 minutes looking at an urban-landscape. This is followed by 20 minutes of independent exploration of the virtual environment by walking. Depending on the user's gait stability, walking aids (such as walking sticks or rollators) may be used. This phase aims at keeping the participant walking.

urban
RuralOTHER

Participants in the intervention groups will receive 5 VR training sessions over 10 days in addition to their usual care. Each participant will wear the HMD for 25 minutes in each of this training sessions, whereby he or she will first sit for 5 minutes looking at a rural-landscape. This is followed by 20 minutes of independent exploration of the virtual environment by walking. Depending on the user's gait stability, walking aids (such as walking sticks or rollators) may be used. This phase aims at keeping the participant walking.

rural

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • age: \> 65 years
  • german-speaking
  • ability to give informed consent
  • attends gait safety training (usual care)
  • inpatient for a duration of min. 2 weeks in one of the study sites
  • items 7 - 15 of the De Morton Mobility Index (DEMMI): min. 2 points, max. 9 points
  • minute walking distance: \> 30 m without rest, with or without walking aids, overground walking on flat surface

You may not qualify if:

  • epilepsy
  • Partial weight bearing or conservatively or surgically treated billing with weight bearing as determined by symptoms
  • Severe hearing impairment (if not corrected with hearing aid)
  • Injuries to the eyes, face, or neck that prevent comfortable use of VR glasses.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Spitäler Schaffhausen

Schaffhausen, Canton of Schaffhausen, 8208, Switzerland

NOT YET RECRUITING

Geriatrische Klinik St. Gallen

Sankt Gallen, Canton of St. Gallen, 9000, Switzerland

NOT YET RECRUITING

Spital Zollikerberg

Zollikerberg, Canton of Zurich, 8125, Switzerland

RECRUITING

MeSH Terms

Interventions

Forests

Intervention Hierarchy (Ancestors)

EcosystemEnvironmentEcological and Environmental PhenomenaBiological PhenomenaEnvironment and Public Health

Study Officials

  • Ulrike Wissen Hayek, Dr.

    ETH Zürich

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Laura Schalbetter, MSc.

CONTACT

Ulrike Wissen Hayek, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a randomized, multi-arm (4-arm), open-label pilot controlled trial with an allocation ratio of 1:1:1:1 (per intervention group (urban, rural, forest) : control). The study setup is multicentric (Geriatrische Klinik St. Gallen, Spitäler Schaffhausen, Spital Zollikerberg).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2024

First Posted

March 12, 2024

Study Start

April 23, 2024

Primary Completion

August 31, 2025

Study Completion

August 31, 2025

Last Updated

March 11, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations